Bayer Seeks Peace in Court With $10.5B Roundup Offer
Synopsis
Bayer is preparing a proposed $10.5 billion plan to settle lawsuits alleging its Roundup weedkiller caused cancer. The litigation began after Bayer acquired Monsanto in 2018. Bayer has already paid about $10 billion in earlier settlements, but many claims remain. The company maintains glyphosate is safe and continues evaluating legal options as Roundup litigation remains a major ongoing legal and financial challenge in the United States.
Bayer is preparing a proposed $10.5 billion plan to settle Roundup cancer lawsuits in the United States. The company inherited the litigation after acquiring Monsanto in 2018. Bayer has already paid about $10 billion in earlier settlements. Thousands of claims remain unresolved as Bayer continues reviewing legal options related to Roundup cases.
Key Highlights
- Bayer preparing about $10.5 billion plan to settle Roundup cancer lawsuits in United States.
- Company inherited litigation after acquiring Monsanto for $63 billion in 2018.
- Bayer has already paid roughly $10 billion to resolve earlier Roundup legal claims.
- Tens of thousands of Roundup lawsuits remain pending in U.S. courts.
Bayer is drafting a proposed plan worth approximately 10.5 billion US dollars to settle a significant portion of lawsuits in the United States over its Roundup weedkiller. The plan will reportedly pay off old debts and minimise future litigation, as reports quotes people involved in the talks indicated.
The lawsuits claim that glyphosate-based herbicide Roundup (initially created by Monsanto) was the cause of cancer, including non-Hodgkin lymphoma. The legal disputes were passed to Bayer after it finalized a 63 billion acquisition of Monsanto in 2018.
The company has already paid an approximate of 10 billion dollars to resolve earlier claims against Roundup since 2020. Nonetheless, there is tens of thousands of pending lawsuits in the U.S. courts. The suggested settlement plan is among the ongoing activities of the company in dealing with the remaining cases and in minimizing uncertainty concerning future legal disputes.
Company response and ongoing legal exposure
On numerous occasions, Bayers has claimed the safety of glyphosate products when used according to the directions and has provided regulatory data to that effect. Simultaneously, a number of court decisions in the United States have been drawn in favor of plaintiffs and this increases the legal and financial liability of the company.
The company has not verified specific financial aspects of the proposal that is reported but has indicated that it is still evaluating legal opportunities in relation to Roundup lawsuits. The cases are also one of the most important legal issues in Bayer since its acquisition of Monsanto.
The cost of Roundup lawsuits has already had a toll on the finances of Bayer and involved recurring legal expenses, as the company is defending its claims and opens settlement opportunities.
Follow Inspirepreneur Magazine for the business breaking news.
Pooja Malik is a business journalist with over six years of experience covering startups, entrepreneurship, and emerging trends. She has previously worked with leading media platforms such as YourStory Media and BW BusinessWorld, where she reported on business, policy, and market developments. Currently, she serves as Editor at The Inspirepreneur Magazine, where she writes and edits stories across business, lifestyle, and travel, with a focus on clarity, accuracy, and reader relevance.
You Might Also Like
Anthropic Warns About AI Risks as Global AI Boom and Market Accelerate
Navi Medical Technologies: Advancing Pediatric Healthcare Solutions
